Aglaia BioMedical Ventures combines its focus on oncology with disciplined financing and a hands-on involvement – up to the level of strategic and operational management – to ensure focus on value creation and capital efficiency: keys to success for early stage companies. New additions to our team should bring complimentary scientific as well as clinical, legal, financial and business development expertise to the company.
If you are interested in joining a dynamic, fast-moving company, which will offer great experience in any of the areas you are suited for, please send us your details and a resumé at firstname.lastname@example.org.
ISA Pharmaceuticals and Regeneron Announce Strategic Immuno-Oncology Collaboration
Cristal Therapeutics awarded €2.5 million Horizon 2020 grant to advance its CriPec®-docetaxel through Phase 2 trials